Covered recipient · General Payments record
J MARK GALBRAITH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,158.92
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $216.33 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $199.58 | 18 |
| Antares Pharma, Inc. | $16.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $16.75 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146459177 | CMS |
| Lilly USA, LLC | $10.33 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987746 | CMS |
| Lilly USA, LLC | $1.56 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031278 | CMS |
| Lilly USA, LLC | $13.56 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135032494 | CMS |
| Lilly USA, LLC | $10.82 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987748 | CMS |
| Lilly USA, LLC | $10.14 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987750 | CMS |
| Lilly USA, LLC | $5.50 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987752 | CMS |
| Lilly USA, LLC | $9.30 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135037789 | CMS |
| Lilly USA, LLC | $10.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014275 | CMS |
| Lilly USA, LLC | $10.68 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135032496 | CMS |
| Lilly USA, LLC | $8.78 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135032498 | CMS |
| Lilly USA, LLC | $12.92 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135011857 | CMS |
| Lilly USA, LLC | $6.42 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014271 | CMS |
| Lilly USA, LLC | $10.62 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031276 | CMS |
| Lilly USA, LLC | $19.81 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987744 | CMS |
| Lilly USA, LLC | $18.12 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135037787 | CMS |
| Lilly USA, LLC | $9.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135011859 | CMS |
| Lilly USA, LLC | $21.95 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014273 | CMS |
| Lilly USA, LLC | $9.03 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987742 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.